Welcome to WiNK Therapeutics: Pioneering the Future of Type 1 Diabetes Treatment

At WiNK Therapeutics, we're dedicated to transforming the lives of individuals with Type 1 diabetes. Our mission is to drive innovation in diabetes care through groundbreaking research and clinical trials, bringing new hope to those affected by this condition.

Our Vision

We envision a world where Type 1 diabetes is no longer a lifelong burden but a manageable condition with effective treatments and, ultimately, a cure. Our work is guided by the belief that every person deserves a life free from the challenges of diabetes.

Why Choose WiNK Therapeutics?

Cutting-Edge Research: WiNK Therapeutics is at the forefront of diabetes research, leveraging the latest scientific advancements to explore new treatment options. Our team of world-class researchers is committed to making a significant impact in the field of diabetes care.

Comprehensive Clinical Trials: We conduct rigorous clinical trials to test innovative therapies, ensuring they are safe, effective, and accessible to those who need them. Our trials are designed with patient well-being as the top priority.

Patient-Centric Approach: At WiNK Therapeutics, patients are at the heart of everything we do. We work closely with participants to provide the best possible care, support, and guidance throughout their journey in our clinical trials.

Our Science

At WiNK Therapeutics, we are pioneering a novel approach to treating Type 1 Diabetes using RNA. This allows us to internally regenerate beta islet cells and also protect these cells from the autoimmunity caused by the disease.